Literature DB >> 33446580

Biomarkers in lung cancer screening: the importance of study design.

David R Baldwin1,2, Matthew E Callister3,4, Philip A Crosbie5,6, Emma L O'Dowd7,2, Robert C Rintoul8,9, Hilary A Robbins10, Robert J C Steele11.   

Abstract

Entities:  

Year:  2021        PMID： 33446580      PMCID： PMC7968073          DOI： 10.1183/13993003.04367-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  22 in total

1.  Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials.

Authors:  Kevin Ten Haaf; Joost van Rosmalen; Harry J de Koning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-13       Impact factor: 4.254

2.  Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

Authors:  Charles-Hugo Marquette; Jacques Boutros; Jonathan Benzaquen; Marion Ferreira; Jean Pastre; Christophe Pison; Bernard Padovani; Faiza Bettayeb; Vincent Fallet; Nicolas Guibert; Damien Basille; Marius Ilie; Véronique Hofman; Paul Hofman
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

3.  Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.

Authors:  Anne Marie Lennon; Adam H Buchanan; Isaac Kinde; Andrew Warren; Ashley Honushefsky; Ariella T Cohain; David H Ledbetter; Fred Sanfilippo; Kathleen Sheridan; Dillenia Rosica; Christian S Adonizio; Hee Jung Hwang; Kamel Lahouel; Joshua D Cohen; Christopher Douville; Aalpen A Patel; Leonardo N Hagmann; David D Rolston; Nirav Malani; Shibin Zhou; Chetan Bettegowda; David L Diehl; Bobbi Urban; Christopher D Still; Lisa Kann; Julie I Woods; Zachary M Salvati; Joseph Vadakara; Rosemary Leeming; Prianka Bhattacharya; Carroll Walter; Alex Parker; Christoph Lengauer; Alison Klein; Cristian Tomasetti; Elliot K Fishman; Ralph H Hruban; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Science       Date:  2020-04-28       Impact factor: 47.728

4.  Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Authors:  Nikolaus Becker; Erna Motsch; Anke Trotter; Claus P Heussel; Hendrik Dienemann; Philipp A Schnabel; Hans-Ulrich Kauczor; Sandra González Maldonado; Anthony B Miller; Rudolf Kaaks; Stefan Delorme
Journal:  Int J Cancer       Date:  2019-06-20       Impact factor: 7.396

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Authors:  Harry J de Koning; Carlijn M van der Aalst; Pim A de Jong; Ernst T Scholten; Kristiaan Nackaerts; Marjolein A Heuvelmans; Jan-Willem J Lammers; Carla Weenink; Uraujh Yousaf-Khan; Nanda Horeweg; Susan van 't Westeinde; Mathias Prokop; Willem P Mali; Firdaus A A Mohamed Hoesein; Peter M A van Ooijen; Joachim G J V Aerts; Michael A den Bakker; Erik Thunnissen; Johny Verschakelen; Rozemarijn Vliegenthart; Joan E Walter; Kevin Ten Haaf; Harry J M Groen; Matthijs Oudkerk
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 91.245

7.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Authors:  Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam
Journal:  Lancet Oncol       Date:  2017-10-18       Impact factor: 41.316

8.  Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.

Authors:  M C Liu; G R Oxnard; E A Klein; C Swanton; M V Seiden
Journal:  Ann Oncol       Date:  2020-03-30       Impact factor: 32.976

9.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139

10.  Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer.

Authors:  Gregory M Gressel; Elaine C Maggi; Bryan E Harmon; Kenny Q Ye; D Y S Kuo; Siobhan M Dolan; Cristina Montagna
Journal:  J Transl Med       Date:  2020-08-27       Impact factor: 5.531
View more
  1 in total

Review 1.  Implementing Lung Cancer Screening in Europe: Taking a Systems Approach.

Authors:  Suzanne Wait; Arturo Alvarez-Rosete; Tasnime Osama; Dani Bancroft; Robin Cornelissen; Ante Marušić; Pilar Garrido; Mariusz Adamek; Jan van Meerbeeck; Annemiek Snoeckx; Olivier Leleu; Ebba Hallersjö Hult; Sébastien Couraud; David R Baldwin
Journal:  JTO Clin Res Rep       Date:  2022-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.